 |
|||||||||||||||||||||
   |
Coverage of 2007 IAS
|
||||||||||||||||||||
| Day Four: New Monoclonal Antibody Drug, PRO140, Shows Promise |
|
| Day Four: Apricitabine Study Shows Promise |
|
| Day Four: Two Studies Report Data on Etravirine |
|
| Day Three: Another Setback for Selzentry |
|
| Day Three: New Experimental NNRTI Starts Very Early Study |
|
| Day Three: New Screening Test May Predict Life-threatening Side Effect of Ziagen |
|
| Day Two: Summary of the Anti-Retroviral Clinical Trials Session |
|
| Day One: Back to the Future? |
|
| Day One: Morning Plenaries and Other News |
IN THE NEWS
ARCHIVES
CONFERENCE
COVERAGE
2007 IAS
PROJECT INFORM
CITED IN MEDIA
© 2008 Project Inform 1375 Mission
Street, San Francisco, CA 94103 415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST